CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 26th Annual JPMorgan Healthcare Conference on Monday, January 7, 2007, at 9:00 a.m. PT (12:00 p.m. ET) at the Westin St. Francis Hotel in San Francisco. This presentation will include a review of the company’s 2007 goals and the key product and business goals for 2008.
